









Markets
/
Stocks
/
nasdaq-cvkd
/

Cadrenal Therapeutics Inc

CVKD

7.110USD

-0.260-3.53%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

14.64MMarket Cap

LossP/E TTM



Cadrenal Therapeutics Inc

7.110

-0.260-3.53%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Cadrenal Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-7.08%-2.36M

-97.86%-3.03M

-153.15%-4.65M

-157.86%-1.79M

-250.64%-2.20M

-92.28%-1.53M

-29.98%-1.84M

-139.29%-694.45K

-50.29%-627.78K

-75.51%-795.31K

-3133.01%-1.41M

---290.22K

---417.71K

---453.14K

---43.70K

Net income from continuing operations

-11.54%-2.69M

-53.25%-3.67M

-131.19%-3.85M

-266.00%-4.19M

-132.31%-2.41M

-138.58%-2.39M

67.85%-1.66M

77.16%-1.14M

-1.01%-1.04M

-99.75%-1.00M

-2828.75%-5.17M

---5.01M

---1.03M

---502.14K

---176.65K

Operating gains losses

-1.23%401.00

-14.68%401.00

824.12%5.52K

-31.83%407.00

-31.99%406.00

-21.14%470.00

214.21%597.00

-21.45%597.00

17.98%597.00

--596.00

--190.00

--760.00

--506.00

----

Other non-cash items

----

100.00%0.00

-245.83%-35.00

-219.10%-106.00

-217.78%-106.00

-100.00%-105.00

-99.94%24.00

-99.52%89.00

-98.92%90.00

149572.85%3.75M

--37.61K

--18.47K

--8.32K

--2.51K

Change in working capital

-55.04%-145.23K

-92.77%48.44K

-303.69%-1.36M

372.13%1.63M

-136.75%-93.67K

1609.48%670.25K

32.15%-336.31K

-2.23%345.88K

185.04%254.92K

9.99%39.21K

-484.55%-495.70K

--353.75K

--89.43K

--35.65K

--128.90K

-Change in prepaid expenses

460.46%242.34K

269.34%217.25K

-161.32%-533.35K

42.15%112.20K

-35.06%43.24K

-12.78%58.82K

27.09%-204.09K

5888.54%78.93K

1720.34%66.59K

364.61%67.44K

-12588.67%-279.91K

--1.32K

--3.66K

---25.48K

---2.21K

-Change in other current assets

--0.00

--1.62K

----

-100.00%0.00

99.97%-1.00

--1.00

99.91%-1.00

300.18%2.20K

---3.79K

--0.00

---1.10K

Cash from non-recurring investing activities

Cash from operating activities

-7.08%-2.36M

-97.86%-3.03M

-153.15%-4.65M

-157.86%-1.79M

-250.64%-2.20M

-92.28%-1.53M

-29.98%-1.84M

-139.29%-694.45K

-50.29%-627.78K

-75.51%-795.31K

-3133.01%-1.41M

---290.22K

---417.71K

---453.14K

---43.70K

Investing cash flow

Net cash flow from investment products

---1.85K

--0.00

---3.25K

---6.54K

----

100.00%0.00

99.96%-1.00

---3.25K

----

---1.00

---2.28K

----

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

---1.85K

--0.00

---3.25K

---6.54K

----

100.00%0.00

99.96%-1.00

---3.25K

----

---1.00

---2.28K

----

Financing cash flow

Cash flow from continuous financing activities

-57.57%648.36K

--1.26M

661019.46%1.97M

59710.28%7.45M

-76.52%1.53M

--0.00

-99.99%298.00

-105.69%-12.50K

1304.20%6.51M

-100.00%0.00

968.80%5.41M

--219.72K

--463.42K

--50.45K

--506.04K

Net cash flow from debt Issuance/repayment

----

100.00%0.00

-100.00%0.00

-150.15%-250.00K

--219.72K

--463.42K

--50.00K

--498.54K

Net cash flow from common stock issuance/repurchase

-56.28%667.98K

--1.29M

--2.06M

66739.57%8.33M

-76.52%1.53M

----

-100.00%0.00

---12.50K

--6.51M

-100.00%0.00

72014.33%5.41M

--0.00

--450.00

--7.50K

Proceeds from stock option exercised by employees

--16.00K

--32.00K

----

Proceeds from issuance of warrants

----

---541.02K

--0.00

-99.88%298.00

--0.00

--250.00K

----

--0.00

----

--0.00

Net cash flow from other financing activities

---35.63K

---63.68K

---85.33K

---337.64K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-57.57%648.36K

--1.26M

661019.46%1.97M

59710.28%7.45M

-76.52%1.53M

--0.00

-99.99%298.00

-105.69%-12.50K

1304.20%6.51M

-100.00%0.00

968.80%5.41M

--219.72K

--463.42K

--50.45K

--506.04K

Net cash flow

Beginning cash balance

10.59%5.57M

11.72%7.34M

19.23%10.02M

-52.09%4.36M

55.96%5.04M

63.00%6.57M

25685.61%8.40M

8737.09%9.11M

5314.96%3.23M

771.30%4.03M

--32.59K

--103.08K

--59.65K

--462.34K

--0.00

Current period cash flow changes

-154.08%-1.71M

-15.44%-1.77M

-46.06%-2.68M

899.79%5.65M

-111.45%-673.27K

-91.50%-1.53M

-145.95%-1.84M

-902.82%-706.95K

13436.33%5.88M

-98.30%-798.56K

764.25%4.00M

---70.50K

--43.44K

---402.69K

--462.34K

Ending cash balance

-11.55%3.86M

10.59%5.57M

11.72%7.34M

19.23%10.02M

-52.09%4.36M

55.96%5.04M

63.00%6.57M

25685.61%8.40M

8737.09%9.11M

5314.96%3.23M

771.30%4.03M

--32.59K

--103.08K

--59.65K

--462.34K

Free cash flow

---2.36M

---3.03M

---4.65M

-157.86%-1.79M

----

-139.29%-694.45K

-50.29%-627.78K

---795.31K

----

---290.22K

---417.71K

----

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

